nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—DPP4—obesity	0.61	1	CbGaD
Adenosine—ADA—brown adipose tissue—obesity	0.0113	0.174	CbGeAlD
Adenosine—SLC28A3—islet of Langerhans—obesity	0.00368	0.0566	CbGeAlD
Adenosine—SLC28A3—respiratory system—obesity	0.00347	0.0535	CbGeAlD
Adenosine—SLC28A3—adipose tissue—obesity	0.00235	0.0361	CbGeAlD
Adenosine—ADA—respiratory system—obesity	0.00226	0.0348	CbGeAlD
Adenosine—SLC28A3—digestive system—obesity	0.00221	0.034	CbGeAlD
Adenosine—ADK—islet of Langerhans—obesity	0.00196	0.0301	CbGeAlD
Adenosine—DPP4—islet of Langerhans—obesity	0.0019	0.0292	CbGeAlD
Adenosine—DPP4—respiratory system—obesity	0.00179	0.0276	CbGeAlD
Adenosine—ADA—cardiovascular system—obesity	0.00173	0.0267	CbGeAlD
Adenosine—ADORA2B—pituitary gland—obesity	0.00168	0.0258	CbGeAlD
Adenosine—ADORA2B—adipose tissue—obesity	0.00167	0.0257	CbGeAlD
Adenosine—ADORA2A—cardiovascular system—obesity	0.00158	0.0243	CbGeAlD
Adenosine—ADK—adrenal cortex—obesity	0.00155	0.0239	CbGeAlD
Adenosine—ADA—adipose tissue—obesity	0.00153	0.0235	CbGeAlD
Adenosine—ADA—digestive system—obesity	0.00144	0.0221	CbGeAlD
Adenosine—Ribavirin—ENPP1—obesity	0.00143	0.23	CrCbGaD
Adenosine—ADK—cardiovascular system—obesity	0.00142	0.0218	CbGeAlD
Adenosine—DPP4—cardiovascular system—obesity	0.00137	0.0211	CbGeAlD
Adenosine—ADA—adrenal gland—obesity	0.00137	0.0211	CbGeAlD
Adenosine—ADORA1—cardiovascular system—obesity	0.00136	0.021	CbGeAlD
Adenosine—ADK—pituitary gland—obesity	0.00125	0.0193	CbGeAlD
Adenosine—ADK—adipose tissue—obesity	0.00125	0.0192	CbGeAlD
Adenosine—ADORA2A—adrenal gland—obesity	0.00125	0.0192	CbGeAlD
Adenosine—DPP4—adipose tissue—obesity	0.00121	0.0186	CbGeAlD
Adenosine—ADORA1—adipose tissue—obesity	0.0012	0.0185	CbGeAlD
Adenosine—ADA—endocrine gland—obesity	0.00119	0.0183	CbGeAlD
Adenosine—DPP4—digestive system—obesity	0.00114	0.0175	CbGeAlD
Adenosine—ADK—adrenal gland—obesity	0.00112	0.0172	CbGeAlD
Adenosine—DPP4—adrenal gland—obesity	0.00109	0.0167	CbGeAlD
Adenosine—ADORA2A—endocrine gland—obesity	0.00108	0.0166	CbGeAlD
Adenosine—ADORA2A—liver—obesity	0.000976	0.015	CbGeAlD
Adenosine—ADK—endocrine gland—obesity	0.000972	0.015	CbGeAlD
Adenosine—DPP4—endocrine gland—obesity	0.000942	0.0145	CbGeAlD
Adenosine—ADORA1—endocrine gland—obesity	0.000934	0.0144	CbGeAlD
Adenosine—ADK—liver—obesity	0.000876	0.0135	CbGeAlD
Adenosine—DPP4—liver—obesity	0.00085	0.0131	CbGeAlD
Adenosine—Adenosine monophosphate—ACSL1—obesity	0.000839	0.135	CrCbGaD
Adenosine—Adenosine triphosphate—ACSL1—obesity	0.000728	0.117	CrCbGaD
Adenosine—Glucosamine—IFNG—obesity	0.000636	0.102	CrCbGaD
Adenosine—Tension—Diethylpropion—obesity	0.000635	0.00391	CcSEcCtD
Adenosine—Chest pain—Phentermine—obesity	0.000633	0.0039	CcSEcCtD
Adenosine—Vidarabine—DPP4—obesity	0.000632	0.101	CrCbGaD
Adenosine—Nervousness—Diethylpropion—obesity	0.000629	0.00387	CcSEcCtD
Adenosine—Hypersensitivity—Methamphetamine—obesity	0.000623	0.00384	CcSEcCtD
Adenosine—Dry mouth—Phentermine—obesity	0.000619	0.00382	CcSEcCtD
Adenosine—Tachycardia—Phenylpropanolamine—obesity	0.000619	0.00381	CcSEcCtD
Adenosine—Vision blurred—Diethylpropion—obesity	0.00061	0.00376	CcSEcCtD
Adenosine—Tremor—Diethylpropion—obesity	0.000606	0.00374	CcSEcCtD
Adenosine—Burning sensation—Topiramate—obesity	0.000602	0.00371	CcSEcCtD
Adenosine—Hypersensitivity—Benzphetamine—obesity	0.0006	0.0037	CcSEcCtD
Adenosine—Nasal congestion—Sibutramine—obesity	0.0006	0.00369	CcSEcCtD
Adenosine—Agitation—Diethylpropion—obesity	0.000595	0.00366	CcSEcCtD
Adenosine—Hypotension—Phenylpropanolamine—obesity	0.000593	0.00365	CcSEcCtD
Adenosine—Tachycardia—Phentermine—obesity	0.000593	0.00365	CcSEcCtD
Adenosine—Atrial fibrillation—Sibutramine—obesity	0.000577	0.00355	CcSEcCtD
Adenosine—Palpitations—Diethylpropion—obesity	0.000572	0.00352	CcSEcCtD
Adenosine—Agitation—Cimetidine—obesity	0.000566	0.00349	CcSEcCtD
Adenosine—Dyspnoea—Phenylpropanolamine—obesity	0.000566	0.00348	CcSEcCtD
Adenosine—Somnolence—Phenylpropanolamine—obesity	0.000564	0.00347	CcSEcCtD
Adenosine—Convulsion—Diethylpropion—obesity	0.000561	0.00345	CcSEcCtD
Adenosine—Dizziness—Methamphetamine—obesity	0.000559	0.00344	CcSEcCtD
Adenosine—Cerebrovascular accident—Sibutramine—obesity	0.000558	0.00343	CcSEcCtD
Adenosine—Chest pain—Diethylpropion—obesity	0.000551	0.00339	CcSEcCtD
Adenosine—Scotoma—Topiramate—obesity	0.000551	0.00339	CcSEcCtD
Adenosine—Anxiety—Diethylpropion—obesity	0.000549	0.00338	CcSEcCtD
Adenosine—Discomfort—Diethylpropion—obesity	0.000544	0.00335	CcSEcCtD
Adenosine—Dizziness—Benzphetamine—obesity	0.000539	0.00332	CcSEcCtD
Adenosine—Dry mouth—Diethylpropion—obesity	0.000539	0.00332	CcSEcCtD
Adenosine—Affect lability—Sibutramine—obesity	0.000538	0.00331	CcSEcCtD
Adenosine—Headache—Methamphetamine—obesity	0.000529	0.00326	CcSEcCtD
Adenosine—Nasal congestion—Bupropion—obesity	0.000523	0.00322	CcSEcCtD
Adenosine—Anxiety—Cimetidine—obesity	0.000522	0.00322	CcSEcCtD
Adenosine—Cardiac arrest—Sibutramine—obesity	0.00052	0.0032	CcSEcCtD
Adenosine—Mood swings—Sibutramine—obesity	0.000518	0.00319	CcSEcCtD
Adenosine—Tachycardia—Diethylpropion—obesity	0.000516	0.00318	CcSEcCtD
Adenosine—Hyperhidrosis—Diethylpropion—obesity	0.000511	0.00315	CcSEcCtD
Adenosine—Headache—Benzphetamine—obesity	0.000511	0.00314	CcSEcCtD
Adenosine—Anaphylactic shock—Cimetidine—obesity	0.000503	0.0031	CcSEcCtD
Adenosine—Dizziness—Phendimetrazine—obesity	0.000491	0.00303	CcSEcCtD
Adenosine—Tachycardia—Cimetidine—obesity	0.000491	0.00302	CcSEcCtD
Adenosine—Cerebrovascular accident—Bupropion—obesity	0.000486	0.00299	CcSEcCtD
Adenosine—Nausea—Benzphetamine—obesity	0.000484	0.00298	CcSEcCtD
Adenosine—Sensory loss—Topiramate—obesity	0.000483	0.00297	CcSEcCtD
Adenosine—Urticaria—Phentermine—obesity	0.000482	0.00297	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Diethylpropion—obesity	0.000481	0.00296	CcSEcCtD
Adenosine—Bronchospasm—Orlistat—obesity	0.00048	0.00296	CcSEcCtD
Adenosine—Dyspnoea—Diethylpropion—obesity	0.000471	0.0029	CcSEcCtD
Adenosine—Somnolence—Diethylpropion—obesity	0.00047	0.00289	CcSEcCtD
Adenosine—Affect lability—Bupropion—obesity	0.000469	0.00289	CcSEcCtD
Adenosine—Abdominal discomfort—Orlistat—obesity	0.000468	0.00288	CcSEcCtD
Adenosine—Hypersensitivity—Phenylpropanolamine—obesity	0.000467	0.00288	CcSEcCtD
Adenosine—Headache—Phendimetrazine—obesity	0.000465	0.00287	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Cimetidine—obesity	0.000458	0.00282	CcSEcCtD
Adenosine—Mood swings—Bupropion—obesity	0.000451	0.00278	CcSEcCtD
Adenosine—Somnolence—Cimetidine—obesity	0.000447	0.00275	CcSEcCtD
Adenosine—Nausea—Phendimetrazine—obesity	0.000441	0.00272	CcSEcCtD
Adenosine—Pollakiuria—Sibutramine—obesity	0.000436	0.00269	CcSEcCtD
Adenosine—Asthenia—Phentermine—obesity	0.000436	0.00268	CcSEcCtD
Adenosine—Atrioventricular block—Topiramate—obesity	0.000431	0.00265	CcSEcCtD
Adenosine—Urticaria—Diethylpropion—obesity	0.00042	0.00258	CcSEcCtD
Adenosine—Dizziness—Phenylpropanolamine—obesity	0.00042	0.00258	CcSEcCtD
Adenosine—Acute coronary syndrome—Sibutramine—obesity	0.000415	0.00256	CcSEcCtD
Adenosine—Myocardial infarction—Sibutramine—obesity	0.000413	0.00254	CcSEcCtD
Adenosine—Glucosamine—MMP9—obesity	0.000405	0.065	CrCbGaD
Adenosine—Bronchospasm—Bupropion—obesity	0.000405	0.00249	CcSEcCtD
Adenosine—Sweating—Sibutramine—obesity	0.000404	0.00249	CcSEcCtD
Adenosine—Vomiting—Phenylpropanolamine—obesity	0.000403	0.00249	CcSEcCtD
Adenosine—Dizziness—Phentermine—obesity	0.000402	0.00247	CcSEcCtD
Adenosine—Rash—Phenylpropanolamine—obesity	0.0004	0.00246	CcSEcCtD
Adenosine—Dermatitis—Phenylpropanolamine—obesity	0.0004	0.00246	CcSEcCtD
Adenosine—Abdominal discomfort—Bupropion—obesity	0.000395	0.00243	CcSEcCtD
Adenosine—Vomiting—Phentermine—obesity	0.000386	0.00238	CcSEcCtD
Adenosine—Bradycardia—Sibutramine—obesity	0.000385	0.00237	CcSEcCtD
Adenosine—Rash—Phentermine—obesity	0.000383	0.00236	CcSEcCtD
Adenosine—Dermatitis—Phentermine—obesity	0.000382	0.00236	CcSEcCtD
Adenosine—Headache—Phentermine—obesity	0.00038	0.00234	CcSEcCtD
Adenosine—Pollakiuria—Bupropion—obesity	0.00038	0.00234	CcSEcCtD
Adenosine—Nausea—Phenylpropanolamine—obesity	0.000377	0.00232	CcSEcCtD
Adenosine—Hypoaesthesia—Sibutramine—obesity	0.000376	0.00232	CcSEcCtD
Adenosine—Hypersensitivity—Cimetidine—obesity	0.00037	0.00228	CcSEcCtD
Adenosine—Acute coronary syndrome—Bupropion—obesity	0.000362	0.00223	CcSEcCtD
Adenosine—Nausea—Phentermine—obesity	0.000361	0.00222	CcSEcCtD
Adenosine—Asthenia—Cimetidine—obesity	0.000361	0.00222	CcSEcCtD
Adenosine—Myocardial infarction—Bupropion—obesity	0.00036	0.00222	CcSEcCtD
Adenosine—Tinnitus—Sibutramine—obesity	0.000352	0.00217	CcSEcCtD
Adenosine—Mediastinal disorder—Orlistat—obesity	0.000352	0.00217	CcSEcCtD
Adenosine—Sweating—Bupropion—obesity	0.000352	0.00217	CcSEcCtD
Adenosine—Dizziness—Diethylpropion—obesity	0.000349	0.00215	CcSEcCtD
Adenosine—Arrhythmia—Sibutramine—obesity	0.000338	0.00208	CcSEcCtD
Adenosine—Vomiting—Diethylpropion—obesity	0.000336	0.00207	CcSEcCtD
Adenosine—Nasal congestion—Topiramate—obesity	0.000333	0.00205	CcSEcCtD
Adenosine—Rash—Diethylpropion—obesity	0.000333	0.00205	CcSEcCtD
Adenosine—Dysgeusia—Orlistat—obesity	0.000333	0.00205	CcSEcCtD
Adenosine—Dermatitis—Diethylpropion—obesity	0.000333	0.00205	CcSEcCtD
Adenosine—Dizziness—Cimetidine—obesity	0.000332	0.00205	CcSEcCtD
Adenosine—Headache—Diethylpropion—obesity	0.000331	0.00204	CcSEcCtD
Adenosine—Back pain—Orlistat—obesity	0.000329	0.00203	CcSEcCtD
Adenosine—Hypoaesthesia—Bupropion—obesity	0.000328	0.00202	CcSEcCtD
Adenosine—Tension—Sibutramine—obesity	0.000323	0.00199	CcSEcCtD
Adenosine—Dysgeusia—Sibutramine—obesity	0.000322	0.00198	CcSEcCtD
Adenosine—Vision blurred—Orlistat—obesity	0.00032	0.00197	CcSEcCtD
Adenosine—Nervousness—Sibutramine—obesity	0.00032	0.00197	CcSEcCtD
Adenosine—Vomiting—Cimetidine—obesity	0.00032	0.00197	CcSEcCtD
Adenosine—Back pain—Sibutramine—obesity	0.000318	0.00196	CcSEcCtD
Adenosine—Rash—Cimetidine—obesity	0.000317	0.00195	CcSEcCtD
Adenosine—Dermatitis—Cimetidine—obesity	0.000317	0.00195	CcSEcCtD
Adenosine—Headache—Cimetidine—obesity	0.000315	0.00194	CcSEcCtD
Adenosine—Nausea—Diethylpropion—obesity	0.000314	0.00193	CcSEcCtD
Adenosine—Angioedema—Orlistat—obesity	0.000311	0.00191	CcSEcCtD
Adenosine—Vision blurred—Sibutramine—obesity	0.00031	0.00191	CcSEcCtD
Adenosine—Tremor—Sibutramine—obesity	0.000308	0.0019	CcSEcCtD
Adenosine—Tinnitus—Bupropion—obesity	0.000307	0.00189	CcSEcCtD
Adenosine—Flushing—Bupropion—obesity	0.000306	0.00188	CcSEcCtD
Adenosine—Cardiac disorder—Bupropion—obesity	0.000306	0.00188	CcSEcCtD
Adenosine—Agitation—Sibutramine—obesity	0.000302	0.00186	CcSEcCtD
Adenosine—S-Adenosylmethionine—COMT—obesity	0.000302	0.0485	CrCbGaD
Adenosine—Angioedema—Sibutramine—obesity	0.000301	0.00185	CcSEcCtD
Adenosine—Palpitations—Orlistat—obesity	0.0003	0.00185	CcSEcCtD
Adenosine—Affect lability—Topiramate—obesity	0.000299	0.00184	CcSEcCtD
Adenosine—Nausea—Cimetidine—obesity	0.000299	0.00184	CcSEcCtD
Adenosine—Mediastinal disorder—Bupropion—obesity	0.000297	0.00183	CcSEcCtD
Adenosine—Cough—Orlistat—obesity	0.000297	0.00183	CcSEcCtD
Adenosine—Syncope—Sibutramine—obesity	0.000295	0.00182	CcSEcCtD
Adenosine—Convulsion—Orlistat—obesity	0.000295	0.00181	CcSEcCtD
Adenosine—Arrhythmia—Bupropion—obesity	0.000294	0.00181	CcSEcCtD
Adenosine—Palpitations—Sibutramine—obesity	0.000291	0.00179	CcSEcCtD
Adenosine—Chest pain—Orlistat—obesity	0.000289	0.00178	CcSEcCtD
Adenosine—Loss of consciousness—Sibutramine—obesity	0.000289	0.00178	CcSEcCtD
Adenosine—Anxiety—Orlistat—obesity	0.000288	0.00178	CcSEcCtD
Adenosine—Mood swings—Topiramate—obesity	0.000287	0.00177	CcSEcCtD
Adenosine—Cough—Sibutramine—obesity	0.000287	0.00177	CcSEcCtD
Adenosine—Discomfort—Orlistat—obesity	0.000286	0.00176	CcSEcCtD
Adenosine—Convulsion—Sibutramine—obesity	0.000285	0.00176	CcSEcCtD
Adenosine—Hypertension—Sibutramine—obesity	0.000284	0.00175	CcSEcCtD
Adenosine—Dry mouth—Orlistat—obesity	0.000283	0.00174	CcSEcCtD
Adenosine—Tension—Bupropion—obesity	0.000281	0.00173	CcSEcCtD
Adenosine—Dysgeusia—Bupropion—obesity	0.000281	0.00173	CcSEcCtD
Adenosine—Chest pain—Sibutramine—obesity	0.00028	0.00173	CcSEcCtD
Adenosine—Anxiety—Sibutramine—obesity	0.000279	0.00172	CcSEcCtD
Adenosine—Nervousness—Bupropion—obesity	0.000279	0.00172	CcSEcCtD
Adenosine—Anaphylactic shock—Orlistat—obesity	0.000277	0.00171	CcSEcCtD
Adenosine—Back pain—Bupropion—obesity	0.000277	0.00171	CcSEcCtD
Adenosine—Discomfort—Sibutramine—obesity	0.000277	0.0017	CcSEcCtD
Adenosine—Dry mouth—Sibutramine—obesity	0.000274	0.00169	CcSEcCtD
Adenosine—Vision blurred—Bupropion—obesity	0.00027	0.00167	CcSEcCtD
Adenosine—Tremor—Bupropion—obesity	0.000269	0.00166	CcSEcCtD
Adenosine—Anaphylactic shock—Sibutramine—obesity	0.000269	0.00165	CcSEcCtD
Adenosine—Hyperhidrosis—Orlistat—obesity	0.000268	0.00165	CcSEcCtD
Adenosine—Glucosamine—TNF—obesity	0.000266	0.0427	CrCbGaD
Adenosine—Shock—Sibutramine—obesity	0.000264	0.00163	CcSEcCtD
Adenosine—Agitation—Bupropion—obesity	0.000264	0.00162	CcSEcCtD
Adenosine—Angioedema—Bupropion—obesity	0.000262	0.00161	CcSEcCtD
Adenosine—Tachycardia—Sibutramine—obesity	0.000262	0.00161	CcSEcCtD
Adenosine—Adenosine triphosphate—AKT1—obesity	0.000261	0.0418	CrCbGaD
Adenosine—Hyperhidrosis—Sibutramine—obesity	0.00026	0.0016	CcSEcCtD
Adenosine—Syncope—Bupropion—obesity	0.000257	0.00158	CcSEcCtD
Adenosine—Palpitations—Bupropion—obesity	0.000253	0.00156	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Orlistat—obesity	0.000253	0.00156	CcSEcCtD
Adenosine—Loss of consciousness—Bupropion—obesity	0.000252	0.00155	CcSEcCtD
Adenosine—Abdominal discomfort—Topiramate—obesity	0.000251	0.00155	CcSEcCtD
Adenosine—Hypotension—Sibutramine—obesity	0.000251	0.00155	CcSEcCtD
Adenosine—Cough—Bupropion—obesity	0.00025	0.00154	CcSEcCtD
Adenosine—Paraesthesia—Orlistat—obesity	0.000249	0.00153	CcSEcCtD
Adenosine—Convulsion—Bupropion—obesity	0.000249	0.00153	CcSEcCtD
Adenosine—Hypertension—Bupropion—obesity	0.000248	0.00153	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Sibutramine—obesity	0.000245	0.00151	CcSEcCtD
Adenosine—Chest pain—Bupropion—obesity	0.000244	0.0015	CcSEcCtD
Adenosine—Anxiety—Bupropion—obesity	0.000243	0.0015	CcSEcCtD
Adenosine—Pollakiuria—Topiramate—obesity	0.000242	0.00149	CcSEcCtD
Adenosine—Discomfort—Bupropion—obesity	0.000241	0.00149	CcSEcCtD
Adenosine—Paraesthesia—Sibutramine—obesity	0.000241	0.00149	CcSEcCtD
Adenosine—Dyspnoea—Sibutramine—obesity	0.000239	0.00147	CcSEcCtD
Adenosine—Dry mouth—Bupropion—obesity	0.000239	0.00147	CcSEcCtD
Adenosine—Somnolence—Sibutramine—obesity	0.000239	0.00147	CcSEcCtD
Adenosine—Pain—Orlistat—obesity	0.000237	0.00146	CcSEcCtD
Adenosine—Anaphylactic shock—Bupropion—obesity	0.000234	0.00144	CcSEcCtD
Adenosine—Shock—Bupropion—obesity	0.00023	0.00142	CcSEcCtD
Adenosine—Pain—Sibutramine—obesity	0.00023	0.00141	CcSEcCtD
Adenosine—Tachycardia—Bupropion—obesity	0.000228	0.00141	CcSEcCtD
Adenosine—Hyperhidrosis—Bupropion—obesity	0.000226	0.00139	CcSEcCtD
Adenosine—Urticaria—Orlistat—obesity	0.00022	0.00136	CcSEcCtD
Adenosine—Hypotension—Bupropion—obesity	0.000219	0.00135	CcSEcCtD
Adenosine—Bradycardia—Topiramate—obesity	0.000214	0.00132	CcSEcCtD
Adenosine—Urticaria—Sibutramine—obesity	0.000213	0.00131	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Bupropion—obesity	0.000213	0.00131	CcSEcCtD
Adenosine—Paraesthesia—Bupropion—obesity	0.00021	0.00129	CcSEcCtD
Adenosine—Hypoaesthesia—Topiramate—obesity	0.000209	0.00129	CcSEcCtD
Adenosine—Dyspnoea—Bupropion—obesity	0.000209	0.00129	CcSEcCtD
Adenosine—Somnolence—Bupropion—obesity	0.000208	0.00128	CcSEcCtD
Adenosine—Glucosamine—CYP2E1—obesity	0.000205	0.0329	CrCbGaD
Adenosine—Hypersensitivity—Orlistat—obesity	0.000204	0.00126	CcSEcCtD
Adenosine—Cytarabine—SLC22A1—obesity	0.0002	0.0321	CrCbGaD
Adenosine—Pain—Bupropion—obesity	0.0002	0.00123	CcSEcCtD
Adenosine—Asthenia—Orlistat—obesity	0.000199	0.00123	CcSEcCtD
Adenosine—Hypersensitivity—Sibutramine—obesity	0.000198	0.00122	CcSEcCtD
Adenosine—Tinnitus—Topiramate—obesity	0.000196	0.00121	CcSEcCtD
Adenosine—Cardiac disorder—Topiramate—obesity	0.000195	0.0012	CcSEcCtD
Adenosine—Flushing—Topiramate—obesity	0.000195	0.0012	CcSEcCtD
Adenosine—Asthenia—Sibutramine—obesity	0.000193	0.00119	CcSEcCtD
Adenosine—Mediastinal disorder—Topiramate—obesity	0.000189	0.00117	CcSEcCtD
Adenosine—Urticaria—Bupropion—obesity	0.000186	0.00115	CcSEcCtD
Adenosine—Cladribine—SLC22A1—obesity	0.000184	0.0295	CrCbGaD
Adenosine—Dizziness—Orlistat—obesity	0.000183	0.00113	CcSEcCtD
Adenosine—Tension—Topiramate—obesity	0.000179	0.0011	CcSEcCtD
Adenosine—Dysgeusia—Topiramate—obesity	0.000179	0.0011	CcSEcCtD
Adenosine—Dizziness—Sibutramine—obesity	0.000178	0.00109	CcSEcCtD
Adenosine—Nervousness—Topiramate—obesity	0.000178	0.00109	CcSEcCtD
Adenosine—Back pain—Topiramate—obesity	0.000177	0.00109	CcSEcCtD
Adenosine—Vomiting—Orlistat—obesity	0.000176	0.00109	CcSEcCtD
Adenosine—Rash—Orlistat—obesity	0.000175	0.00108	CcSEcCtD
Adenosine—Dermatitis—Orlistat—obesity	0.000175	0.00108	CcSEcCtD
Adenosine—Headache—Orlistat—obesity	0.000174	0.00107	CcSEcCtD
Adenosine—Hypersensitivity—Bupropion—obesity	0.000172	0.00106	CcSEcCtD
Adenosine—Vision blurred—Topiramate—obesity	0.000172	0.00106	CcSEcCtD
Adenosine—Tremor—Topiramate—obesity	0.000171	0.00105	CcSEcCtD
Adenosine—Vomiting—Sibutramine—obesity	0.000171	0.00105	CcSEcCtD
Adenosine—Rash—Sibutramine—obesity	0.000169	0.00104	CcSEcCtD
Adenosine—Dermatitis—Sibutramine—obesity	0.000169	0.00104	CcSEcCtD
Adenosine—Headache—Sibutramine—obesity	0.000168	0.00104	CcSEcCtD
Adenosine—Asthenia—Bupropion—obesity	0.000168	0.00103	CcSEcCtD
Adenosine—Agitation—Topiramate—obesity	0.000168	0.00103	CcSEcCtD
Adenosine—Nausea—Orlistat—obesity	0.000165	0.00102	CcSEcCtD
Adenosine—Syncope—Topiramate—obesity	0.000164	0.00101	CcSEcCtD
Adenosine—Palpitations—Topiramate—obesity	0.000162	0.000995	CcSEcCtD
Adenosine—Loss of consciousness—Topiramate—obesity	0.000161	0.000989	CcSEcCtD
Adenosine—Nausea—Sibutramine—obesity	0.00016	0.000983	CcSEcCtD
Adenosine—Cough—Topiramate—obesity	0.000159	0.000982	CcSEcCtD
Adenosine—Convulsion—Topiramate—obesity	0.000158	0.000975	CcSEcCtD
Adenosine—Hypertension—Topiramate—obesity	0.000158	0.000972	CcSEcCtD
Adenosine—Chest pain—Topiramate—obesity	0.000156	0.000958	CcSEcCtD
Adenosine—Anxiety—Topiramate—obesity	0.000155	0.000955	CcSEcCtD
Adenosine—Dizziness—Bupropion—obesity	0.000155	0.000954	CcSEcCtD
Adenosine—Discomfort—Topiramate—obesity	0.000154	0.000947	CcSEcCtD
Adenosine—Dry mouth—Topiramate—obesity	0.000152	0.000937	CcSEcCtD
Adenosine—Vomiting—Bupropion—obesity	0.000149	0.000917	CcSEcCtD
Adenosine—Rash—Bupropion—obesity	0.000148	0.000909	CcSEcCtD
Adenosine—Dermatitis—Bupropion—obesity	0.000147	0.000908	CcSEcCtD
Adenosine—Shock—Topiramate—obesity	0.000147	0.000904	CcSEcCtD
Adenosine—Headache—Bupropion—obesity	0.000147	0.000903	CcSEcCtD
Adenosine—Tachycardia—Topiramate—obesity	0.000146	0.000897	CcSEcCtD
Adenosine—Hyperhidrosis—Topiramate—obesity	0.000144	0.000888	CcSEcCtD
Adenosine—S-Adenosylmethionine—CYP2E1—obesity	0.000141	0.0226	CrCbGaD
Adenosine—Hypotension—Topiramate—obesity	0.000139	0.000859	CcSEcCtD
Adenosine—Nausea—Bupropion—obesity	0.000139	0.000857	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Topiramate—obesity	0.000136	0.000837	CcSEcCtD
Adenosine—Paraesthesia—Topiramate—obesity	0.000134	0.000825	CcSEcCtD
Adenosine—Dyspnoea—Topiramate—obesity	0.000133	0.000819	CcSEcCtD
Adenosine—Somnolence—Topiramate—obesity	0.000133	0.000817	CcSEcCtD
Adenosine—Pain—Topiramate—obesity	0.000128	0.000786	CcSEcCtD
Adenosine—Urticaria—Topiramate—obesity	0.000118	0.00073	CcSEcCtD
Adenosine—Hypersensitivity—Topiramate—obesity	0.00011	0.000677	CcSEcCtD
Adenosine—Asthenia—Topiramate—obesity	0.000107	0.000659	CcSEcCtD
Adenosine—Dizziness—Topiramate—obesity	9.86e-05	0.000608	CcSEcCtD
Adenosine—Vomiting—Topiramate—obesity	9.48e-05	0.000584	CcSEcCtD
Adenosine—Rash—Topiramate—obesity	9.4e-05	0.000579	CcSEcCtD
Adenosine—Dermatitis—Topiramate—obesity	9.4e-05	0.000579	CcSEcCtD
Adenosine—Headache—Topiramate—obesity	9.34e-05	0.000576	CcSEcCtD
Adenosine—Nausea—Topiramate—obesity	8.86e-05	0.000546	CcSEcCtD
Adenosine—ADORA1—Signaling Pathways—CNR1—obesity	1.59e-05	0.000102	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NCF2—obesity	1.57e-05	0.0001	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—HTR2A—obesity	1.57e-05	0.0001	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TCF7L2—obesity	1.56e-05	0.0001	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—C3—obesity	1.56e-05	9.99e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GNB3—obesity	1.56e-05	9.96e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—AKT2—obesity	1.56e-05	9.95e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—DRD2—obesity	1.55e-05	9.93e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CG—obesity	1.54e-05	9.88e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTPN1—obesity	1.54e-05	9.83e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GCG—obesity	1.54e-05	9.83e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—TYK2—obesity	1.54e-05	9.82e-05	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CB—obesity	1.53e-05	9.8e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PIK3CA—obesity	1.53e-05	9.8e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF2—obesity	1.53e-05	9.79e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NPY—obesity	1.53e-05	9.76e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—RHOA—obesity	1.52e-05	9.74e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GNAS—obesity	1.52e-05	9.7e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APOC3—obesity	1.52e-05	9.7e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IAPP—obesity	1.52e-05	9.7e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3R1—obesity	1.51e-05	9.64e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CD—obesity	1.5e-05	9.56e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APOB—obesity	1.49e-05	9.5e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AGT—obesity	1.49e-05	9.5e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HTR1B—obesity	1.47e-05	9.41e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CRH—obesity	1.47e-05	9.41e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—POMC—obesity	1.47e-05	9.4e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CG—obesity	1.47e-05	9.38e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PRL—obesity	1.47e-05	9.38e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SDC1—obesity	1.46e-05	9.31e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PRKCD—obesity	1.45e-05	9.29e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCL5—obesity	1.45e-05	9.28e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—STK11—obesity	1.45e-05	9.24e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCL2—obesity	1.44e-05	9.2e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKR1C3—obesity	1.43e-05	9.16e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PLG—obesity	1.43e-05	9.14e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—RHOA—obesity	1.43e-05	9.12e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HTR2A—obesity	1.42e-05	9.09e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—C3—obesity	1.42e-05	9.08e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—LPL—obesity	1.42e-05	9.07e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PPARG—obesity	1.42e-05	9.05e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKT2—obesity	1.41e-05	9.04e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3R1—obesity	1.41e-05	9.03e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FOXO1—obesity	1.41e-05	9.01e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RPS6KB1—obesity	1.41e-05	8.99e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—POMC—obesity	1.4e-05	8.93e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NPS—obesity	1.4e-05	8.93e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FOXO3—obesity	1.39e-05	8.92e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CB—obesity	1.39e-05	8.9e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ADRB2—obesity	1.39e-05	8.9e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—INS—obesity	1.39e-05	8.88e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PRKCB—obesity	1.37e-05	8.78e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—F2—obesity	1.37e-05	8.78e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SOCS1—obesity	1.37e-05	8.76e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HTR2C—obesity	1.37e-05	8.75e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—DRD1—obesity	1.37e-05	8.75e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CD—obesity	1.36e-05	8.68e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IL6—obesity	1.36e-05	8.68e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SOCS3—obesity	1.35e-05	8.65e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AGT—obesity	1.35e-05	8.62e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NTRK2—obesity	1.33e-05	8.51e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADRB1—obesity	1.33e-05	8.48e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GNB3—obesity	1.33e-05	8.47e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CG—obesity	1.31e-05	8.4e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PRKCD—obesity	1.31e-05	8.36e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—TYK2—obesity	1.31e-05	8.35e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CB—obesity	1.3e-05	8.33e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF2—obesity	1.3e-05	8.32e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PARP1—obesity	1.3e-05	8.3e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GHRL—obesity	1.3e-05	8.3e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—RHOA—obesity	1.3e-05	8.28e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GNAS—obesity	1.29e-05	8.25e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CD—obesity	1.29e-05	8.25e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—DRD4—obesity	1.29e-05	8.23e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3R1—obesity	1.28e-05	8.2e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HTR2A—obesity	1.28e-05	8.18e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—C3—obesity	1.28e-05	8.17e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—ALB—obesity	1.27e-05	8.14e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APOB—obesity	1.26e-05	8.08e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—AKT1—obesity	1.25e-05	8e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—POMC—obesity	1.25e-05	7.99e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—F2—obesity	1.25e-05	7.97e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PRKCB—obesity	1.25e-05	7.97e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL5—obesity	1.23e-05	7.89e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CNR1—obesity	1.23e-05	7.86e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—NOS3—obesity	1.22e-05	7.79e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3R1—obesity	1.22e-05	7.79e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IRS2—obesity	1.22e-05	7.77e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AGT—obesity	1.21e-05	7.76e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TCF7L2—obesity	1.21e-05	7.72e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—LPL—obesity	1.21e-05	7.71e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT2—obesity	1.2e-05	7.68e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—DRD2—obesity	1.2e-05	7.67e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FOXO1—obesity	1.2e-05	7.66e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RPS6KB1—obesity	1.2e-05	7.64e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CG—obesity	1.19e-05	7.63e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APOE—obesity	1.19e-05	7.6e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—LEP—obesity	1.19e-05	7.6e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GCG—obesity	1.19e-05	7.59e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTPN1—obesity	1.19e-05	7.59e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CB—obesity	1.18e-05	7.57e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CAV1—obesity	1.18e-05	7.53e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APOA1—obesity	1.18e-05	7.52e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CD—obesity	1.15e-05	7.38e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ESR1—obesity	1.14e-05	7.26e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—POMC—obesity	1.14e-05	7.26e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PRL—obesity	1.13e-05	7.24e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CB—obesity	1.12e-05	7.19e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PRKCB—obesity	1.12e-05	7.17e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—F2—obesity	1.12e-05	7.17e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STK11—obesity	1.12e-05	7.14e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS2—obesity	1.11e-05	7.12e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PRKCD—obesity	1.11e-05	7.11e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCL2—obesity	1.11e-05	7.1e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—BAD—obesity	1.11e-05	7.09e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PLG—obesity	1.1e-05	7.06e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—RHOA—obesity	1.1e-05	7.04e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT2—obesity	1.09e-05	6.98e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3R1—obesity	1.09e-05	6.97e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HTR2A—obesity	1.09e-05	6.95e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—C3—obesity	1.09e-05	6.94e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FOXO3—obesity	1.08e-05	6.89e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADRB2—obesity	1.07e-05	6.87e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CG—obesity	1.07e-05	6.86e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IRS1—obesity	1.06e-05	6.78e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SOCS1—obesity	1.06e-05	6.76e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CD—obesity	1.05e-05	6.7e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SOCS3—obesity	1.05e-05	6.68e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IRS2—obesity	1.03e-05	6.61e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AGT—obesity	1.03e-05	6.6e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GNB3—obesity	1.02e-05	6.54e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—POMC—obesity	1.02e-05	6.53e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—INS—obesity	1.02e-05	6.5e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APOE—obesity	1.01e-05	6.47e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—LEP—obesity	1.01e-05	6.47e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—TYK2—obesity	1.01e-05	6.45e-05	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CA—obesity	1.01e-05	6.45e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CB—obesity	1.01e-05	6.43e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF2—obesity	1e-05	6.42e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CAV1—obesity	1e-05	6.41e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—RHOA—obesity	1e-05	6.4e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCL2—obesity	1e-05	6.39e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APOA1—obesity	1e-05	6.39e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GNAS—obesity	9.96e-06	6.37e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3R1—obesity	9.9e-06	6.33e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF1—obesity	9.83e-06	6.28e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT2—obesity	9.82e-06	6.28e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APOB—obesity	9.75e-06	6.24e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ESR1—obesity	9.65e-06	6.17e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—F2—obesity	9.54e-06	6.1e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PRKCB—obesity	9.54e-06	6.1e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL5—obesity	9.53e-06	6.09e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CD—obesity	9.44e-06	6.03e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—BAD—obesity	9.42e-06	6.02e-05	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CA—obesity	9.35e-06	5.98e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SERPINE1—obesity	9.33e-06	5.97e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—LPL—obesity	9.31e-06	5.96e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FOXO1—obesity	9.25e-06	5.91e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RPS6KB1—obesity	9.23e-06	5.9e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CB—obesity	9.14e-06	5.84e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CG—obesity	9.13e-06	5.83e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TYK2—obesity	9.08e-06	5.8e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IRS1—obesity	9.02e-06	5.77e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RHOA—obesity	9e-06	5.76e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3R1—obesity	8.91e-06	5.7e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOS3—obesity	8.91e-06	5.7e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—POMC—obesity	8.69e-06	5.55e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—INS—obesity	8.64e-06	5.52e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PRKCD—obesity	8.58e-06	5.49e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL2—obesity	8.5e-06	5.43e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CA—obesity	8.49e-06	5.43e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HTR2A—obesity	8.4e-06	5.37e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—C3—obesity	8.39e-06	5.36e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF1—obesity	8.36e-06	5.34e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT2—obesity	8.35e-06	5.34e-05	CbGpPWpGaD
Adenosine—ADK—Metabolism—AKT1—obesity	8.24e-06	5.27e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MTOR—obesity	8.22e-06	5.26e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CB—obesity	8.22e-06	5.26e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CD—obesity	8.02e-06	5.13e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IRS2—obesity	7.98e-06	5.1e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AGT—obesity	7.97e-06	5.09e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CA—obesity	7.95e-06	5.08e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SERPINE1—obesity	7.93e-06	5.07e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—LEP—obesity	7.81e-06	4.99e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APOE—obesity	7.81e-06	4.99e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CAV1—obesity	7.74e-06	4.95e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APOA1—obesity	7.72e-06	4.93e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TYK2—obesity	7.72e-06	4.93e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RHOA—obesity	7.65e-06	4.89e-05	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—AKT1—obesity	7.63e-06	4.88e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3R1—obesity	7.58e-06	4.84e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOS3—obesity	7.58e-06	4.84e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6—obesity	7.51e-06	4.8e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ESR1—obesity	7.45e-06	4.77e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PRKCB—obesity	7.36e-06	4.71e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—F2—obesity	7.36e-06	4.71e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—BAD—obesity	7.28e-06	4.65e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CA—obesity	7.22e-06	4.61e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP9—obesity	7.15e-06	4.57e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CG—obesity	7.05e-06	4.5e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MTOR—obesity	6.99e-06	4.47e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CB—obesity	6.99e-06	4.47e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IRS1—obesity	6.96e-06	4.45e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAPK8—obesity	6.95e-06	4.44e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—AKT1—obesity	6.93e-06	4.43e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CA—obesity	6.85e-06	4.38e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—POMC—obesity	6.71e-06	4.29e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—INS—obesity	6.67e-06	4.26e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL2—obesity	6.56e-06	4.2e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—AKT1—obesity	6.49e-06	4.15e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF1—obesity	6.45e-06	4.12e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT2—obesity	6.45e-06	4.12e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6—obesity	6.39e-06	4.09e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—STAT3—obesity	6.36e-06	4.06e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CD—obesity	6.19e-06	3.96e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CA—obesity	6.14e-06	3.92e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SERPINE1—obesity	6.13e-06	3.92e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP9—obesity	6.08e-06	3.89e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TYK2—obesity	5.96e-06	3.81e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAPK8—obesity	5.91e-06	3.78e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RHOA—obesity	5.91e-06	3.78e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MYC—obesity	5.91e-06	3.78e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKT1—obesity	5.89e-06	3.77e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TGFB1—obesity	5.89e-06	3.77e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOS3—obesity	5.85e-06	3.74e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3R1—obesity	5.85e-06	3.74e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—AKT1—obesity	5.6e-06	3.58e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CA—obesity	5.57e-06	3.56e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—STAT3—obesity	5.4e-06	3.46e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MTOR—obesity	5.4e-06	3.45e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CB—obesity	5.4e-06	3.45e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MYC—obesity	5.02e-06	3.21e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CA—obesity	5.01e-06	3.21e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT1—obesity	5.01e-06	3.2e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TGFB1—obesity	5.01e-06	3.2e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6—obesity	4.93e-06	3.15e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP9—obesity	4.69e-06	3e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAPK8—obesity	4.56e-06	2.92e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT1—obesity	4.55e-06	2.91e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6—obesity	4.44e-06	2.84e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CA—obesity	4.26e-06	2.73e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STAT3—obesity	4.17e-06	2.67e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT1—obesity	4.1e-06	2.62e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MYC—obesity	3.88e-06	2.48e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFB1—obesity	3.87e-06	2.47e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6—obesity	3.77e-06	2.41e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT1—obesity	3.48e-06	2.23e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CA—obesity	3.29e-06	2.1e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6—obesity	2.91e-06	1.86e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT1—obesity	2.69e-06	1.72e-05	CbGpPWpGaD
